平安健康開啟線上“疫診”通道 全方位助力抗疫
近期疫情反覆，多地再次開啟疫情嚴防嚴控模式，不少居民的工作生活受到了較大影響。當面臨醫療健康等方面的問題時，外出尋醫問藥，受到了諸多限制。
為助力疫情防控，方便居民就醫，平安健康醫療科技有限公司(股票簡稱“平安好醫生”，1833.HK)積極發揮互聯網醫療“高效、及時、無傳染風險”的優勢，快速開啟線上“疫診”通道，為有醫療和健康需求的居民，無償提供7*24小時在線問診服務，即時解決大家問診、買藥不方便的問題。
足不出户體驗一站式就醫服務
據瞭解，平安健康此次線上“疫診”的服務範圍，涵蓋內科、外科、婦科、兒科、中醫科、皮膚科等20個科室。在社區被封控管理的情況下，通過平安健康線上“疫診”通道，居民足不出户就能享受在線問診、開方、購藥、送藥到家等專業、便捷、信任的醫療健康服務，真正助力實現“省心、省時又省錢”。
針對患有高血壓、糖尿病、冠心病等慢性病，且有長期服用藥物需求的患者，“疫診”通道提供了極大的便利。患者只需通過手機即可與醫生進行音視頻問診，在線購藥後，藥品即可快速送到家中。醫生還可以根據患者身體狀況，給出詳細指導，幫助患者調整藥物劑量，切實解決看病難、買藥難的問題。
心理諮詢師緩解焦慮情緒
由於疫情持續打亂居民的日常生活和工作節奏，關於“焦慮、抑鬱”問題的心理諮詢逐漸增多。通過線上“疫診”通道，平安健康的心理諮詢師們為有需求的用户進行線上心理諮詢，傾聽來訪者內心的聲音。用户可以傾訴各種困擾自己的問題，通過平台得到心理諮詢師專業的迴應。此外，心理諮詢師還通過平台為用户分享居家隔離期間調試心理的方法，幫助舒緩負面情緒，提供有温度的服務。
在“疫診”通道的背後，體現的是平安健康的醫療健康和科技的實力。平安健康的自有醫療團隊和AI輔助診療系統7*24小時迅速回應用户需求；超4.8萬名內外部醫生團隊及健康師、營養師和心理諮詢師全面覆蓋健康、亞健康、疾病、慢病、養老等服務場景；合作的超1100外部名醫服務有高質量醫療服務需求的各渠道用户。
自疫情爆發以來，平安健康專業的醫療團隊積極為用户提供問診、產品、資訊等各類醫療健康服務，積極探索以多種方式踐行社會責任，多方位助力抗疫。未來，平安健康將持續發揮互聯網醫療及時、高效、避免線下交叉感染的優勢，為用户築造健康防線。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
